𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A CD2/CD28 chimeric receptor triggers the CD28 signaling pathway in CTLL.2 cells

✍ Scribed by Feldhaus, A L; Evans, L; Sutherland, R A; Jones, L A


Book ID
110038040
Publisher
Nature Publishing Group
Year
1997
Tongue
English
Weight
323 KB
Volume
4
Category
Article
ISSN
0969-7128

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Signaling via CD28 costimulates lymphoki
✍ Frank Sommer; Martin RΓΆllinghoff; Michael Lohoff πŸ“‚ Article πŸ“… 1993 πŸ› John Wiley and Sons 🌐 English βš– 485 KB

## Signaling via CD28 costimulates lymphokine production, but does not reverse unresponsiveness to interleukin-2 in anti-CD3 triggered T h l cells* Mikrobiologie, Universitat Erlangen-Nurnberg, Erlangen Previously, it has been described that the ability of murineTh1 cells to proliferate in respons

Adenosine inhibits activation-induced T
✍ Jared J. Butler; Jamie S. Mader; Carrie L. Watson; Hong Zhang; Jonathan Blay; Da πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 562 KB

## Abstract Adenosine is an immunosuppressive molecule that is associated with the microenvironment of solid tumors. Mouse T cells activated with anti‐CD3 antibody in the presence of adenosine with or without coformycin (to prevent adenosine breakdown by adenosine deaminase) exhibited decreased tyr

Costimulation by chimeric antigen recept
✍ Andreas A. Hombach; Hinrich Abken πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 French βš– 830 KB

## Abstract The therapeutic success of adoptive therapy with chimeric antigen receptor (CAR) engineered T cells depends on the appropriate costimulation of CD3ΞΆ to induce full T cell activation. Costimulatory endodomains of the CD28 family are therefore fused with CD3ΞΆ in a dual signalling CAR. Ser